Lansoprazole Pinewood Laboratories

Lansoprazole, the active ingredient in Lansoprazole Pinewood Laboratories, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat acid‑related disorders such as GERD, peptic ulcer disease, and erosive esophagitis.

GNH USA supplies Lansoprazole Pinewood Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor used to manage conditions associated with excess gastric acid.

- Gastroesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence. - Erosive esophagitis: heals erosive lesions in the esophagus. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.

Lansoprazole may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild pain in the head region. - Diarrhea: loose, watery stools. - Nausea: feeling of sickness.

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome): skin rash, blistering, and mucosal involvement. - Clostridium difficile‑associated diarrhea: severe colitis requiring medical attention. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.

Before starting therapy, consider the following precautions.

- Assess renal and hepatic function: evaluate baseline organ status. - Use caution in elderly patients: increased sensitivity to acid suppression. - Monitor serum magnesium during prolonged treatment: risk of hypomagnesemia. - Avoid abrupt discontinuation: taper if used long‑term to prevent rebound acid hypersecretion. - Review concomitant medications: check for potential drug interactions. - Store at ambient temperature: keep in the original pack, protect from moisture.

Lansoprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clarithromycin: increased lansoprazole levels may lead to toxicity. - Ketoconazole: reduced absorption of ketoconazole, risking treatment failure. - Atazanavir: decreased atazanavir exposure, compromising HIV therapy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in anticoagulant effect; monitor INR. - Phenytoin: reduced phenytoin concentrations may require dose adjustment. - Digoxin: possible rise in digoxin levels; monitor serum concentrations.